USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment

Endometrial adenocarcinoma is the most common gynecologic malignancy in the United States. Most endometrial cancer cases are diagnosed at an early stage and have good prognosis. Unfortunately a subset of patients with early stage and low grade disease experience recurrence for reasons that remain un...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogel, Rachel Isaksson, Pulver, Tanya, Heilmann, Wiebke, Mooneyham, Ashley, Mullany, Sally, Zhao, Xianda, Shahi, Maryam, Richter, James, Klein, Molly, Chen, Liqiang, Ding, Rui, Konecny, Gottfried, Kommoss, Stefan, Winterhoff, Boris, Ghebre, Rahel, Bazzaro, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058731/
https://www.ncbi.nlm.nih.gov/pubmed/27121063
http://dx.doi.org/10.18632/oncotarget.8821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058731/
https://www.ncbi.nlm.nih.gov/pubmed/27121063
http://dx.doi.org/10.18632/oncotarget.8821

Ejemplares similares